Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2025-01-07 00:00:00 ET · period of report 2025-01-03 · accession 0001415889-25-001046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-07 | 2025-01-03+ | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | — | +16.7K | 27.9K | +149% | — |
| DM | 2025-01-07 | 2025-01-03+ | ANAB | Lizzul Paul F. | Chief Medical Off | F - Tax | $14.84 | -6,597 | 25.6K | -20% | -$97.9K |
| DM | 2025-01-07 | 2025-01-03+ | ANAB | Lizzul Paul F. | Chief Medical Off | M - OptEx | $0.00 | -16.7K | 31.7K | -35% | $0 |
| DM | 2025-01-07 | 2025-01-07 | ANAB | Lizzul Paul F. | Chief Medical Off | A - Grant | $0.00 | +131.3K | 97.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-03 | M | A | 10,555 | — | 26,095 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F2) Reflects the acquisition of 142 shares acquired under the Company's ESPP. |
| 2 | Common | Common Stock | 2025-01-03 | F | D | 4,336 | $14.60 | 21,759 | D | — | — | (F3) Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. (F4) The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes. |
| 3 | Common | Common Stock | 2025-01-06 | F | D | 2,261 | $15.30 | 25,643 | D | — | — | (F3) Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation. (F4) The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes. |
| 4 | Common | Common Stock | 2025-01-06 | M | A | 6,145 | — | 27,904 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 5 | Derivative | Restricted Stock Unit | 2025-01-06 | M | D | 6,145 | $0.00 | 12,290 | D | — · — to — | 6,145 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F6) The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 6 | Derivative | Restricted Stock Unit | 2025-01-07 | A | A | 34,100 | $0.00 | 34,100 | D | — · — to — | 34,100 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F7) The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 7 | Derivative | Restricted Stock Unit | 2025-01-03 | M | D | 10,555 | $0.00 | 31,665 | D | — · — to — | 10,555 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F5) The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| 8 | Derivative | Stock Option (right to buy) | 2025-01-07 | A | A | 97,200 | $0.00 | 97,200 | D | $14.83 · — to 2035-01-06 | 97,200 Common Stock | (F8) The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |